Akzo Signed Biotech Supply Agreement
14-Feb-2005
Under the terms of the deal, Diosynth Biotechnology is responsible for technology transfer, purification-process development, scaling-up and the commercial production of Pharming's rhC1INH at its large-scale downstream processing facility in Oss, the Netherlands. The facility has been FDA inspected and currently produces commercial products. The financial terms of the agreement have not been disclosed.
Topics
Organizations
AkzoNobel
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.